Life Sciences Partners has participated in a EUR 8m financing round for Finnish medical device company Nexstim . New investors Healthcap and Finnish Industry Investment Ltd have also contributed along with existing investor Sitra. In connection with the new share issue, Dr. René Kuijten from LSP and Dr. Johan Christenson from HealthCap will join Nexstim's board of directors.
Pechel, via Pechel IV, and the co-investment team of Omnes back the French IT services firm
Connection Capital provided £6.7m to support the buyout of the business in 2017
Temasek previously led a £7m investment for the technology developer in 2016
Opportunities for growth expected to come from increasing demand for point-of-sale products